Cargando…

Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease

BACKGROUND: We hypothesised that the radiomics signature, which includes texture information of dopamine transporter single-photon emission computed tomography (DAT-SPECT) images for Parkinson’s disease (PD), may assist semi-quantitative indices. Herein, we constructed a radiomics signature using DA...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiiba, Takuro, Takano, Kazuki, Takaki, Akihiro, Suwazono, Shugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237203/
https://www.ncbi.nlm.nih.gov/pubmed/35759054
http://dx.doi.org/10.1186/s13550-022-00910-1
_version_ 1784736720615374848
author Shiiba, Takuro
Takano, Kazuki
Takaki, Akihiro
Suwazono, Shugo
author_facet Shiiba, Takuro
Takano, Kazuki
Takaki, Akihiro
Suwazono, Shugo
author_sort Shiiba, Takuro
collection PubMed
description BACKGROUND: We hypothesised that the radiomics signature, which includes texture information of dopamine transporter single-photon emission computed tomography (DAT-SPECT) images for Parkinson’s disease (PD), may assist semi-quantitative indices. Herein, we constructed a radiomics signature using DAT-SPECT-derived radiomics features that effectively discriminated PD from healthy individuals and evaluated its classification performance. RESULTS: We analysed 413 cases of both normal control (NC, n = 101) and PD (n = 312) groups from the Parkinson’s Progression Markers Initiative database. Data were divided into the training and two test datasets with different SPECT manufacturers. DAT-SPECT images were spatially normalised to the Montreal Neurologic Institute space. We calculated 930 radiomics features, including intensity- and texture-based features in the caudate, putamen, and pallidum volumes of interest. The striatum uptake ratios (SURs) of the caudate, putamen, and pallidum were also calculated as conventional semi-quantification indices. The least absolute shrinkage and selection operator was used for feature selection and construction of the radiomics signature. The four classification models were constructed using a radiomics signature and/or semi-quantitative indicator. Furthermore, we compared the classification performance of the semi-quantitative indicator alone and the combination with the radiomics signature for the classification models. The receiver operating characteristics (ROC) analysis was used to evaluate the classification performance. The classification performance of SUR(putamen) was higher than that of other semi-quantitative indicators. The radiomics signature resulted in a slightly increased area under the ROC curve (AUC) compared to SUR(putamen) in each test dataset. When combined with SUR(putamen) and radiomics signature, all classification models showed slightly higher AUCs than that of SUR(putamen) alone. CONCLUSION: We constructed a DAT-SPECT image-derived radiomics signature. Performance analysis showed that the current radiomics signature would be helpful for the diagnosis of PD and has the potential to provide robust diagnostic performance.
format Online
Article
Text
id pubmed-9237203
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92372032022-06-29 Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease Shiiba, Takuro Takano, Kazuki Takaki, Akihiro Suwazono, Shugo EJNMMI Res Original Research BACKGROUND: We hypothesised that the radiomics signature, which includes texture information of dopamine transporter single-photon emission computed tomography (DAT-SPECT) images for Parkinson’s disease (PD), may assist semi-quantitative indices. Herein, we constructed a radiomics signature using DAT-SPECT-derived radiomics features that effectively discriminated PD from healthy individuals and evaluated its classification performance. RESULTS: We analysed 413 cases of both normal control (NC, n = 101) and PD (n = 312) groups from the Parkinson’s Progression Markers Initiative database. Data were divided into the training and two test datasets with different SPECT manufacturers. DAT-SPECT images were spatially normalised to the Montreal Neurologic Institute space. We calculated 930 radiomics features, including intensity- and texture-based features in the caudate, putamen, and pallidum volumes of interest. The striatum uptake ratios (SURs) of the caudate, putamen, and pallidum were also calculated as conventional semi-quantification indices. The least absolute shrinkage and selection operator was used for feature selection and construction of the radiomics signature. The four classification models were constructed using a radiomics signature and/or semi-quantitative indicator. Furthermore, we compared the classification performance of the semi-quantitative indicator alone and the combination with the radiomics signature for the classification models. The receiver operating characteristics (ROC) analysis was used to evaluate the classification performance. The classification performance of SUR(putamen) was higher than that of other semi-quantitative indicators. The radiomics signature resulted in a slightly increased area under the ROC curve (AUC) compared to SUR(putamen) in each test dataset. When combined with SUR(putamen) and radiomics signature, all classification models showed slightly higher AUCs than that of SUR(putamen) alone. CONCLUSION: We constructed a DAT-SPECT image-derived radiomics signature. Performance analysis showed that the current radiomics signature would be helpful for the diagnosis of PD and has the potential to provide robust diagnostic performance. Springer Berlin Heidelberg 2022-06-27 /pmc/articles/PMC9237203/ /pubmed/35759054 http://dx.doi.org/10.1186/s13550-022-00910-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Shiiba, Takuro
Takano, Kazuki
Takaki, Akihiro
Suwazono, Shugo
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title_full Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title_fullStr Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title_full_unstemmed Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title_short Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
title_sort dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting parkinson’s disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237203/
https://www.ncbi.nlm.nih.gov/pubmed/35759054
http://dx.doi.org/10.1186/s13550-022-00910-1
work_keys_str_mv AT shiibatakuro dopaminetransportersinglephotonemissioncomputedtomographyderivedradiomicssignaturefordetectingparkinsonsdisease
AT takanokazuki dopaminetransportersinglephotonemissioncomputedtomographyderivedradiomicssignaturefordetectingparkinsonsdisease
AT takakiakihiro dopaminetransportersinglephotonemissioncomputedtomographyderivedradiomicssignaturefordetectingparkinsonsdisease
AT suwazonoshugo dopaminetransportersinglephotonemissioncomputedtomographyderivedradiomicssignaturefordetectingparkinsonsdisease